Tempus AI Wins FDA Clearance for ECG Pulmonary Hypertension Tool
Chicago, Illinois, USA, Aug 26, 2026 Tempus AI, Inc. has received U.S. Food and Drug Administration (FDA) 510(k) clearance...
AI healthcare
Advertisement
Enhanced Group Launches AI-Powered Enhanced OS
New York, August 18, 2026 Enhanced Group, Inc. (NYSE: ENHA) has announced Enhanced OS, an AI-powered platform designed to...
Pulsenmore Advances AI-Powered Home Ultrasound Technology
RAMAT GAN, Israel — August 17, 2026 Pulsenmore Ltd. has received a $1.27 million grant from the Israel Innovation...
Andor Health Advances AI-Native Virtual Nursing With MUSC
Orlando, Florida, USA, August, 10, 2026 Independent research from the Medical University of South Carolina (MUSC) Telehealth Center of...
FDA Licenses First-Ever Freeze-Dried Plasma Product in U.S.
SILVER SPRING, Md., July 29, 2026 The U.S. Food and Drug Administration (FDA) has licensed Ezplaz Freeze Dried Plasma...
Advertisements
Leads Biolabs Gains China IND for Opamtistomig in mCRC
NANJING, China, August 3, 2026 Leads Biolabs announced that the Center for Drug Evaluation (CDE) of China’s National Medical...
Avenda Health Expands Unfold AI Across Prostate Cancer Care
CULVER CITY, Calif., July 28, 2026 Avenda Health announced that its FDA-cleared Unfold AI platform is now being used...
Hippocratic AI Launches Rapid Response Climate Agents for Healthcare
MENLO PARK, Calif., July 31, 2026 Hippocratic AI has launched a new suite of Rapid Response Climate Agents, enabling...
Dario Expands Obesity Care with AI-Powered GLP-1 Program
NEW YORK, July 30, 2026 DarioHealth Corp. has unveiled its Integrated GLP-1 Program, a comprehensive healthcare solution that combines...
CSL Reports Positive Phase 3b Results for Pediatric ANDEMBRY
KING OF PRUSSIA, Pa., July 27, 2026 CSL has announced positive top-line Phase 3b clinical trial results supporting plans...
Advertisement
